CVE:GSD Devonian Health Group (GSD) Stock Price, News & Analysis C$0.15 0.00 (0.00%) As of 07/28/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Devonian Health Group Stock (CVE:GSD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Devonian Health Group alerts:Sign Up Key Stats Today's RangeC$0.15▼C$0.1550-Day RangeC$0.11▼C$0.1952-Week RangeC$0.08▼C$0.35Volume1,400 shsAverage Volume17,120 shsMarket CapitalizationC$22.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada. Read More Receive GSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address GSD Stock News HeadlinesDevonian Health Group Reports Third Quarter 2025 Financial ResultsJune 26, 2025 | financialpost.comFDevonian Health Group Reports Second Quarter 2025 Financial ResultsApril 15, 2025 | financialpost.comFThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important updates you'll ever see. A new initiative, linked to President Trump's Executive Order #14196, has the potential to do more than just protect Social Security from collapse... According to renowned investor Louis Navellier, it could increase benefits by as much as 400%.August 2 at 2:00 AM | InvestorPlace (Ad)Devonian Health Group Faces Cease Trade Order Amid Filing DelaysApril 14, 2025 | tipranks.comDevonian Health Group Reports Cease Trade OrderApril 14, 2025 | financialpost.comFDevonian Health Group Delays Financial Reporting Due to Restatement NeedsApril 1, 2025 | tipranks.comDevonian Reports Delay of Financial ReportingApril 1, 2025 | financialpost.comFDevonian Health Group Files Patent for Thykamine™ as Antifibrotic AgentFebruary 19, 2025 | tipranks.comSee More Headlines GSD Stock Analysis - Frequently Asked Questions How have GSD shares performed this year? Devonian Health Group's stock was trading at C$0.16 at the beginning of the year. Since then, GSD shares have decreased by 6.3% and is now trading at C$0.15. How do I buy shares of Devonian Health Group? Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryComputer Software Current SymbolCVE:GSD CIKN/A Webwww.groupedevonian.com Phone450-937-6696FaxN/AEmployees6Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$3.17 million Net Margins-32.50% Pretax MarginN/A Return on Equity-23.31% Return on Assets-8.12% Debt Debt-to-Equity Ratio16.36 Current Ratio1.07 Quick Ratio7.82 Sales & Book Value Annual SalesC$9.75 million Price / Sales2.28 Cash FlowC$0.02 per share Price / Cash Flow6.10 Book ValueC$0.09 per share Price / Book1.67Miscellaneous Outstanding Shares148,220,000Free FloatN/AMarket CapC$22.23 million OptionableNot Optionable Beta1.28 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (CVE:GSD) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Devonian Health Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Devonian Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.